ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1828

Adverse Pregnancy Outcomes in Adolescents and Young Women with Systemic Lupus Erythematosus: A National Estimate

Nicole Ling1, Isabel E. Allen2, Erica F. Lawson1 and Emily von Scheven3, 1Pediatrics, University of California, San Francisco, San Francisco, CA, 2Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 3Pediatric Rheumatology, University of California, San Francisco, San Francisco, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Adolescent patients, outcomes and pregnancy, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose: Pregnant women with SLE have increased risk of adverse outcomes including lupus flare, spontaneous abortion, preeclampsia/eclampsia, premature birth and maternal death, but pregnancy outcomes among adolescents and young women with SLE have not been well-explored. Our goal was to compare pregnancy outcomes among adolescents and young women with and without SLE, and to identify associated risk factors.

Methods: We studied the 2000-2011 Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality. The NIS contains annual discharge data from all-payer hospital stays from about 1,000 nationwide hospitals, to approximate a 20% stratified sample of U.S. community hospitals. Hospitalizations of individuals age 21 or less with ICD-9 discharge diagnoses associated with pregnancy were included (delivery, liveborn, abortion, ectopic pregnancy, or intrauterine death). SLE hospitalizations were identified by a 710.0 ICD-9 code. After applying sampling weights, unadjusted odds ratios to estimate the risk of adverse pregnancy outcomes among individuals with and without SLE were calculated. Multi-variate logistic regression was performed to examine the independent effect of age, race, and socio-economic status on pre-eclampsia/eclampsia.

Results: 9,125,224 estimated hospitalizations were included in the analysis, of which 4,142 had SLE. Hospitalized women with SLE were slightly older (mean age 19.4 with range 14-21 vs.19 with range 8-21), more likely to be black (34% v. 21%), more likely to carry a discharge diagnosis of nephritis (11% v. 0.02%) or aPL (2.7% v. 0.1%), and more likely to undergo hemodialysis (0.35% v. 0.0%), all p<0.0001. Socioeconomic status represented by median household income quartiles for patient zip codes were not different across groups.

Table 1:  Unadjusted weighted estimates of outcomes of unique pregnancies by hospital discharge data in those with and without SLE

Outcome

 SLE

N = 4,142

Non-SLE

N = 9,121,082

P*

OR (95%CI) +

N (%) unless noted

Maternal Outcomes

     Pre-eclampsia and Eclampsia

657 (16)

417,676 (4.6)

<0.0001

3.9 (3.3 4.7)

     Death during hospitalization

15 (0.37)

490 (0.005)

<0.0001

69.7 (22.6 214.6)

Fetal Outcomes

     Preterm

843 (20)

736,665 (8.1)

<0.0001

2.9 (2.5 3.4)

     Low birth weight or fetal growth retardation

0 (0)

20 (0)

0.97

1 (0.0004 0.0005)

     Spontaneous abortion or Intrauterine death

179 (4.3)

99,426 (1.1)

<0.0001

4.1 (2.9 5.8)

     Induced abortion

90 (2.2)

11,749 (0.13)

<0.0001

17.2 (10.4 28.3)

     Ectopic pregnancy

²10 (²0.24)⌃

30,293 (0.3)

0.61

0.7 (0.17 2.78)

     Congenital Anomalies

58 (1.4)

29,185 (0.32)

<0.0001

4.4 (2.5 7.8)

* CHI2 Analysis

+ Unadjusted logistic regression

⌃Unable to report cell sizes less than or equal to 10, per HCUP data use regulations.

Conclusion: This large national dataset demonstrated increased risk of pre-eclampsia/eclampsia, maternal death, preterm labor, spontaneous and induced abortion, and congenital anomalies in pregnant adolescents and young women with SLE compared to those without SLE.  This is similar to previous findings in the literature regarding adult women with SLE. Disease duration and activity, medication exposure and age of SLE onset for the study population are not known. Additional analyses are planned to further explore outcomes with multivariate modeling and to characterize risk factors associated with poor pregnancy outcomes among adolescents and young women with SLE.


Disclosure:

N. Ling,
None;

I. E. Allen,
None;

E. F. Lawson,
None;

E. von Scheven,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adverse-pregnancy-outcomes-in-adolescents-and-young-women-with-systemic-lupus-erythematosus-a-national-estimate/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology